Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Luise Dunham

Monitoring Manager, Oncology Clinical Trials Office (OCTO)

I joined the Oncology Clinical Trials Office in 2006, originally as a Clinical Trial Monitor. Now I oversee the monitoring activities across the early phase portfolio, with particular involvement in the following trials currently:

NuTide:301: A two-part, Phase 1 open-label dose escalation and expansion study to assess safety, pharmacokinetics and clinical activity of NUC-3373, a nucleotide analogue, in participants with advanced solid tumours. 

LUD2015-005: Phase 1/2 Study of anti-PD-L1 in Combination with Chemo(radio)therapy for Oesophageal Cancer